Monaldi Archives for Chest Disease

Scope & Guideline

Advancing Knowledge in Chest Disease Research

Introduction

Explore the comprehensive scope of Monaldi Archives for Chest Disease through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Monaldi Archives for Chest Disease in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1122-0643
PublisherPAGEPRESS PUBL
Support Open AccessYes
CountryItaly
TypeJournal
Convergefrom 1993 to 2024
AbbreviationMONALDI ARCH CHEST D / Monaldi Arch. Chest Dis.
Frequency3 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressMEDITGROUP, VIA G BELLI, 4, PAVIA 27100, ITALY

Aims and Scopes

The Monaldi Archives for Chest Disease focuses on advancing knowledge in pulmonary and cardiovascular medicine through diverse clinical, epidemiological, and therapeutic research. Its aim is to provide a platform for innovative studies that impact clinical practice and improve patient outcomes.
  1. Pulmonary Diseases Research:
    The journal emphasizes research on various pulmonary conditions, including tuberculosis, chronic obstructive pulmonary disease (COPD), asthma, and interstitial lung diseases, contributing significantly to understanding these diseases' pathophysiology, diagnosis, and management.
  2. Cardiovascular Health Studies:
    Research related to cardiovascular diseases, including heart failure, myocardial infarction, and arrhythmias, is a core area. The journal publishes studies that explore the intersection of respiratory and cardiac health, particularly in complex cases.
  3. Infectious Diseases and Public Health:
    There is a strong focus on infectious diseases, especially tuberculosis and COVID-19, reflecting the journal's commitment to addressing global health challenges and providing insights into treatment protocols and public health strategies.
  4. Innovative Therapeutic Approaches:
    The journal highlights studies on new therapeutic interventions, including pharmacological treatments, rehabilitation strategies, and innovative surgical techniques, aimed at improving patient outcomes in respiratory and cardiovascular care.
  5. Clinical and Epidemiological Studies:
    Monaldi Archives prioritizes epidemiological research that informs clinical practice, assessing risk factors, treatment outcomes, and healthcare delivery models to enhance understanding and management of chest diseases.
Recent publications have highlighted several emerging themes in the journal, reflecting current trends in chest disease research and addressing contemporary healthcare challenges.
  1. COVID-19 Impact and Management:
    The journal has seen a surge in studies focused on the effects of COVID-19 on respiratory and cardiovascular health, including post-acute sequelae, treatment strategies, and healthcare system responses, indicating a major shift in research focus due to the pandemic.
  2. Telemedicine and Remote Patient Management:
    With the rise of telehealth during the pandemic, there is an emerging trend in studies evaluating the effectiveness of telemedicine in managing chronic respiratory and cardiovascular diseases, showcasing innovative approaches to patient care.
  3. Multidisciplinary Approaches to Treatment:
    There is a growing emphasis on multidisciplinary treatment strategies that integrate various specialties, such as pulmonology, cardiology, and rehabilitation, in managing complex patients, reflecting a trend towards holistic patient care.
  4. Environmental and Socioeconomic Factors:
    Research exploring the impact of environmental factors, such as air pollution, on respiratory diseases has gained traction, highlighting the importance of understanding social determinants of health in managing chest diseases.
  5. Personalized Medicine and Biomarkers:
    There is an increasing focus on personalized medicine, including studies on biomarkers for disease prediction and treatment response, showcasing a shift towards tailored therapeutic strategies in respiratory and cardiovascular care.

Declining or Waning

While the journal continues to cover a wide range of topics, certain areas have shown a decline in publication frequency or relevance, reflecting shifting priorities in research and clinical practice.
  1. Traditional Surgical Techniques:
    There has been a noticeable decrease in studies focusing solely on traditional surgical techniques for respiratory diseases, possibly due to the rise of minimally invasive and endoscopic methods that are gaining preference in clinical practice.
  2. Basic Science and Laboratory Studies:
    Research focusing on basic science aspects of pulmonary and cardiovascular diseases is less prevalent, as the journal increasingly emphasizes clinical and translational studies that directly impact patient care.
  3. Longitudinal Studies in Chronic Diseases:
    The frequency of longitudinal studies examining chronic respiratory or cardiac conditions has waned, potentially reflecting a shift towards more immediate, short-term outcome studies in the context of recent global health crises.

Similar Journals

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Fostering interdisciplinary collaboration in respiratory medicine.
Publisher: AMER THORACIC SOCISSN: 1073-449XFrequency: 24 issues/year

American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine

Connecting Researchers and Practitioners in Clinical Medicine
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5484Frequency: 1 issue/year

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine, published by SAGE Publications Ltd, stands as a vital resource in the fields of Cardiology and Pulmonary Medicine, underscored by its Q3 quartile rankings in both areas for 2023. Established in 2007 as an open-access journal, it facilitates the dissemination of cutting-edge research and observations from the international scientific community. With an ISSN of 1179-5484, the journal has garnered recognition for its contributions to clinical medicine, particularly covering topics of circulatory, respiratory, and pulmonary health. The journal not only aims to bridge the gap between research and clinical practice but also to serve as a platform for innovative ideas and collaborations among researchers, healthcare professionals, and trainees. By offering unrestricted access to its articles, Clinical Medicine Insights ensures that vital knowledge reaches a broad audience, ultimately fostering advancements in medical science and patient care.

Lung India

Pioneering the future of respiratory research.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0970-2113Frequency: 6 issues/year

Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.

CHEST

Transforming critical care through innovative studies.
Publisher: ELSEVIERISSN: 0012-3692Frequency: 12 issues/year

CHEST is a premier journal published by Elsevier, focusing on the vital fields of cardiology, critical care, and pulmonary medicine. Established in 1970, this esteemed journal has continually provided authoritative research, reviews, and clinical studies, catering to a global audience of healthcare professionals, researchers, and students. With an impressive impact factor, CHEST ranks in the top quartile (Q1) across its core categories according to the latest Scopus metrics, securing its position as a leading resource within cardiology (Rank #16), pulmonary (Rank #9), and critical care (Rank #8). Published quarterly, it offers a wealth of knowledge essential for advancing understanding and improving patient outcomes in these critical areas of healthcare. Researchers and practitioners are encouraged to submit their work, contributing to the ongoing discourse that shapes innovative practices and policies in respiratory and cardiovascular health.

RESPIRATION

Pioneering Research for Enhanced Patient Health
Publisher: KARGERISSN: 0025-7931Frequency: 12 issues/year

RESPIRATION is a prestigious journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine, with a commitment to publishing high-quality, peer-reviewed research. Established in 1944 and published by KARGER in Switzerland, this journal has maintained an exemplary impact within the scientific community, currently holding a Q1 ranking in the 2023 category for Pulmonary and Respiratory Medicine, placing it among the top 18% of journals in its field. With an ISSN of 0025-7931 and an E-ISSN of 1423-0356, RESPIRATION provides a platform for researchers and professionals to disseminate original studies, reviews, and clinical cases that shape contemporary understanding and treatment of respiratory diseases. The journal's rigorous standards for publication ensure that it remains a vital resource for the latest innovations and findings. As part of its mission, RESPIRATION seeks to bridge the gap between clinical practice and research, fostering multidisciplinary collaboration and enhancing patient outcomes. The journal is readily accessible, ensuring that vital research reaches a broad audience of healthcare professionals and academic scholars globally.

Revista de la Federacion Argentina de Cardiologia

Fostering collaboration to enhance cardiovascular care.
Publisher: FEDERACION ARGENTINA CARDIOLOGIAISSN: 0326-646XFrequency: 4 issues/year

Revista de la Federacion Argentina de Cardiologia is a vital publication in the field of Cardiology and Cardiovascular Medicine, providing a platform for researchers and healthcare professionals to share significant findings and innovative concepts since its inception in 2012. Published by the Federacion Argentina Cardiology, this journal specifically addresses contemporary issues and advancements within cardiology, contributing to the scholarly dialogue essential for improving cardiovascular health. Despite being categorized in the Q4 quartile for 2023 and presently ranking #358 out of 387 in its field, the journal remains committed to fostering academic inquiry and disseminating valuable research for both local and global audiences. Although it is not an open-access journal, it strives to balance accessibility with rigorous academic standards, ensuring quality contributions that are critical for practitioners and students alike. The journal’s ongoing evaluation and adaptation in the ever-evolving landscape of cardiology underscore its importance in advancing cardiovascular science and practice.

Netherlands Heart Journal

Leading the Way in Cardiovascular Research and Practice
Publisher: BOHN STAFLEU VAN LOGHUM BVISSN: 1568-5888Frequency: 12 issues/year

Netherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.

Annals of Thoracic Medicine

Connecting researchers and practitioners in thoracic health.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1817-1737Frequency: 4 issues/year

Annals of Thoracic Medicine is a prominent open-access journal, published by Wolters Kluwer Medknow Publications, focusing on the critical fields of cardiology, pulmonary and respiratory medicine, and surgery. With an ISSN of 1817-1737 and an E-ISSN of 1998-3557, this journal aims to disseminate cutting-edge research, clinical findings, and innovative practices that can significantly impact the health outcomes of patients dealing with thoracic diseases. Since its inception in 2006, it has established itself as a reputable source of knowledge, achieving Q2 quartile rankings in 2023 across its main categories. Currently ranked #126 in Medicine & Surgery and exhibiting a growing SCOPUS percentile, the journal plays an essential role in advancing the understanding and treatment of thoracic conditions. Open access options ensure that research is readily available to a global audience, facilitating collaboration and knowledge sharing among researchers, healthcare professionals, and students in the field.

Canadian Journal of Respiratory Critical Care and Sleep Medicine

Pioneering research in respiratory health and intensive care.
Publisher: TAYLOR & FRANCIS INCISSN: 2474-5332Frequency: 4 issues/year

Welcome to the Canadian Journal of Respiratory Critical Care and Sleep Medicine, a prestigious peer-reviewed journal published by Taylor & Francis Inc. With an ISSN of 2474-5332 and an E-ISSN of 2474-5340, this journal serves as a vital platform for disseminating cutting-edge research in the fields of critical care, intensive care medicine, and pulmonary and respiratory medicine. Since its inception in 2017, the journal has established itself within the academic community, currently holding a Q2 ranking in Critical Care and Intensive Care Medicine and a Q3 ranking in Pulmonary and Respiratory Medicine for 2023. Although it operates under a standard access model, the journal remains committed to providing valuable insights and advancing knowledge through rigorous research articles, reviews, and case studies. Positioned in the heart of the United States, the journal aims to foster collaboration and innovation among healthcare professionals, researchers, and students dedicated to enhancing respiratory care and critical treatment protocols. Join us in exploring the dynamic intersection of research and practice that defines our mission.

BMC Pulmonary Medicine

Empowering innovation in pulmonary medicine for a healthier tomorrow.
Publisher: BMCISSN: 1471-2466Frequency: 1 issue/year

BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.